Aspire Private Capital’s Apexigen, Inc. WarrantApexigen, Inc. Warrant APGNW Stock Holding History

Aspire Private Capital’s Portfolio APGNW Stock Details APGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-100	Closed	-$3	–	691
2022 Q4	$3	Hold	100	–	–	﹤0.01%	656
2022 Q3	$0	Buy	+100	New	+$25	﹤0.01%	689
2022 Q2	–	Sell	-100	Closed	–	–	660
2022 Q1	$0	Hold	100	–	–	﹤0.01%	689
2021 Q4	$0	Buy	+100	New	+$69	﹤0.01%	681
2021 Q3	–	Sell	-100	Closed	–	–	652
2021 Q2	$0	Buy	+100	New	+$163	﹤0.01%	642

Other funds holding APGNW

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

Skaana Management Brooklyn, New York $296M AUM 65.1% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Aspire Private Capital's APGNW Position: Q1 2023 in Review

Aspire Private Capital sold out of Apexigen, Inc. WarrantApexigen, Inc. Warrant (APGNW) in Q1 2023, closing a stake of 100 shares — an estimated $3 sold.

Aspire Private Capital first reported a position in APGNW in Q2 2021 and held it in 5 quarters. The position peaked at $3 in Q4 2022. 16 funds tracked by Wall St. Rank hold APGNW as of Q1 2023.

Aspire Private Capital reported no remaining Apexigen, Inc. WarrantApexigen, Inc. Warrant position as of Q1 2023 after selling out during the quarter.
Aspire Private Capital sold 100 Apexigen, Inc. WarrantApexigen, Inc. Warrant shares in Q1 2023, an estimated $3.
Aspire Private Capital first reported a position in Apexigen, Inc. WarrantApexigen, Inc. Warrant in Q2 2021 and held it in 5 quarters.
Aspire Private Capital's Apexigen, Inc. WarrantApexigen, Inc. Warrant position peaked at $3 in Q4 2022.
16 funds tracked by Wall St. Rank held Apexigen, Inc. WarrantApexigen, Inc. Warrant as of Q1 2023.

Based on Aspire Private Capital's 13F filing for Q1 2023, filed 3 May 2023.